164. Oculocutaneous albinism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 17 / Drugs : 57 - (DrugBank : 32) / Drug target genes : 32 - Drug target pathways : 139
| Other names | Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; | ||
|---|---|---|---|
| Disease group | Eye diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
32 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 10-4-31. Chédiak-Higashi syndrome; CHS | ||
| 14-1-1. oculocutaneous albinism; OCA | |||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | - | ||